Literature DB >> 11471311

[Reversible posterior leukoencephalopathy, severe hypertension, and cocaine abuse].

E Rodríguez Gómez1, F J Rodríguez Gómez, M J Merino, A Robledo, J M López Domínguez, F Fernández Girón, J González Martínez.   

Abstract

Reversible posterior leukoencephalopathy syndrome is a brain disorder characterized by headache, nausea, vomiting, visual disturbance, depressed level of consciousness, convulsions and occasionally focal neurologic deficits. It is commonly associated with malignant hypertension, toxemia of pregnancy or the use of immunosuppressive agents. Early diagnosis and specific treatment is essential. We report a case of reversible posterior leukoencephalopathy in the context of a hypertensive crisis in an habitual cocaine sniffer. Reversible posterior leukoencephalopathy must be suspected in every patient with hypertensive crisis and compatible clinic manifestation. Neuroimaging studies show characteristic features which confirm the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11471311

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


  4 in total

1.  Posterior reversible encephalopathy syndrome (PRES) complicating the 'legal high' mephedrone.

Authors:  Taha Adam Omer; Colin Doherty
Journal:  BMJ Case Rep       Date:  2011-08-29

Review 2.  [Headache and hypertension. Myth and evidence].

Authors:  T Liman; E Siebert; M Endres
Journal:  Nervenarzt       Date:  2010-08       Impact factor: 1.214

3.  Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus.

Authors:  Stephane Legriel; Fabrice Bruneel; Odile Spreux-Varoquaux; Aurelie Birenbaum; Marie Laure Chadenat; François Mignon; Nathalie Abbosh; Matthieu Henry-Lagarrigue; Laure Revault D'Allonnes; Pierre Guezennec; Gilles Troche; Jean Pierre Bedos
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

4.  Posterior reversible encephalopathy syndrome associated with the use of chemotherapeutic agents: a rare complication after treatment with vinorelbine.

Authors:  Ines Gil; Filipa Serrazina; Miguel Pinto; Miguel Viana-Baptista
Journal:  BMJ Case Rep       Date:  2020-02-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.